Compounds > 3,4-dihydroxyphenylacetic acid
Page last updated: 2024-10-17

3,4-dihydroxyphenylacetic acid and Central Hypothyroidism

3,4-dihydroxyphenylacetic acid has been researched along with Central Hypothyroidism in 3 studies

3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Del Compare, JA1
Aguirre, JA1
Ibarra, FR1
Barontini, M1
Armando, I1
Vaccari, A2
Stefanini, E2
de Montis, G2
Rossetti, ZL2
Martino, E1
Gessa, GL1

Other Studies

3 other studies available for 3,4-dihydroxyphenylacetic acid and Central Hypothyroidism

ArticleYear
Effects of thyroid hormone on the renal dopaminergic system.
    Endocrine, 2001, Volume: 15, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antithyroid Agents; Benzazepines; Catechols; Dihydroxypheny

2001
Dopaminergic dysfunction in neonatal hypothyroidism: differential effects of GM1 ganglioside.
    Neuropharmacology, 1990, Volume: 29, Issue:12

    Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Animals, Newborn; Corpus Striatum; Dopam

1990
Neonatal hypothyroidism induces striatal dopaminergic dysfunction.
    Neuroscience, 1990, Volume: 35, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Benzazepines; Body Weight; Corpus Striatu

1990